Cargando…

Minimal assessment of index cases: the point of view of the neurologist

Detalles Bibliográficos
Autor principal:	Hund, Ernst
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642032/ http://dx.doi.org/10.1186/1750-1172-10-S1-I11

Ejemplares similares

Which assessment for the carriers ? The point of view of the neurologist
por: Conceicão, Isabel
Publicado: (2015)

Minimal assessment of the index case: the point of view of the cardiologist
por: Slama, Michel
Publicado: (2015)

Which assessment for the carriers: the cardiac view
por: Kristen, Arnt V
Publicado: (2015)

Is the international classification of healthcare procedures (ICHI) a critical point for the implementation of an international Casemix grouper?
por: Rodrigues, Jean-Marie
Publicado: (2012)

Risk assessment of biotechnology products
por: Herouet-Guicheney, Corinne
Publicado: (2011)

The practical application of biomechanical theory for patient assessment
por: Prior, Trevor D
Publicado: (2011)

Challenges in assessing the potential allergenicity of biotechnology products
por: Goodman, Richard
Publicado: (2011)

Allergenicity assessment of GMOs by the European safety authority
por: Wal, Jean Michel
Publicado: (2011)

Assessment of risk from food allergens cross-contamination
por: Alldrick, Anton
Publicado: (2011)

Clinical thresholds in food allergy and their application in risk assessment management
por: Houben, Geert
Publicado: (2011)

PReS13-SPK-1332: Assessment of disease activity and damage in juvenile idiopathic arthritis
por: Ravelli, A
Publicado: (2013)

From start to finish: quantitative allergen risk assessment of foods containing peanut advisory labeling
por: Remington, Ben, et al.
Publicado: (2011)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022)

INSP-04. Confirmatory adaptive designs for survival trials with several time-to-event endpoints
por: Schmidt, Rene
Publicado: (2022)

INSP-08. Cerebellar mutism syndrome: incidence, symptoms, risk factors, prognosis. Results and future perspectives from the Nordic-European study of the cerebellar mutism syndrome
por: Sehested, Astrid, et al.
Publicado: (2022)

INSP-03. Neuronal regulation of glioma progression
por: Monje, Michelle
Publicado: (2022)

INSP-17. Augmented Drug Delivery for Pediatric Diffuse Midline Glioma using Convection Enhanced Delivery
por: Souweidane, Mark M
Publicado: (2022)

INSP-14. Novel approaches to molecular diagnostics
por: Sahm, Felix
Publicado: (2022)

INSP-07. Improving cognitive outcomes for children treated for cancer: moving beyond the cure
por: Conklin, Heather
Publicado: (2022)

INSP-01. What to do when you cannot randomize? Leveraging Historical Data in Efficient Study Designs for Pediatric Neuro-Oncology.
por: Onar-Thomas, Arzu
Publicado: (2022)

INSP-02. WHO 2021 classification of CNS tumors
por: Wesseling, Pieter
Publicado: (2022)

INSP-16. Focused ultrasound-mediated blood-brain barrier disruption for the treatment of pediatric high-grade glioma
por: van Vuurden, Dannis, et al.
Publicado: (2022)

INSP-05. Development of fast cortical rhythms in health and mental disease
por: Hanganu-Opatz, Ileana
Publicado: (2022)

Point of care testing for improving risk- benefit ratio of aspirin and warfarin
por: Sheth, Harsh, et al.
Publicado: (2014)

Functional neuroimaging: the adaptive mechanisms in migraine
por: Tedeschi, Gioacchino, et al.
Publicado: (2015)

Neural plasticity and migraine
por: Coppola, Gianluca
Publicado: (2015)

Cortical spreading depression and familial hemiplegic migraine 2015
por: Pietrobon, Daniela
Publicado: (2015)

Non invasive neurostimulation
por: Grazzi, Licia
Publicado: (2015)

Obesity, diet and nutraceuticals
por: Di Lorenzo, Cherubino, et al.
Publicado: (2015)

Pathogenesis of chronic migraine: the role of neuromodulators
por: D'Andrea, Giovanni
Publicado: (2015)

Migraine and epilepsy: what value today?
por: Costa, Cinzia, et al.
Publicado: (2015)

A proposal for a national registry on chronic migraines
por: Vanacore, Nicola, et al.
Publicado: (2015)

Rehabilitation from symptomatic drugs overuse: yes, no, may be
por: Tassorelli, Cristina, et al.
Publicado: (2015)

Chronic migraine: nosographic and epidemiological issues
por: Manzoni, Gian Camillo, et al.
Publicado: (2015)

Laser evoked potentials and central sensitization in migraine
por: Vecchio, Eleonora, et al.
Publicado: (2015)

Chronic migraine: treatability, refractoriness, pseudo-refractoriness
por: Barbanti, Piero, et al.
Publicado: (2015)

Kynurenine pathway metabolites in migraine
por: Nicoletti, Ferdinando
Publicado: (2015)

The value of epidemiology in headache
por: Beghi, Ettore
Publicado: (2015)

Osmophobia in adult and juvenile headache patients
por: Zanchin, Giorgio
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cqagdas8cfasildqupuluhesos